| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Feb 24, 2016 | IRWD Ironwood Pharmaceuticals Inc | Currie Mark G53 | Chief Scientific Officer | Sell | 152,154 | $8.53 | $1,297,809.00 | -27.6% | |
| Feb 24, 2016 | ELTP Elite Pharmaceuticals Inc /nv/ | Treppel Jerry | Former Chairman | Sell | 200,456 | $0.32 | $63,231.36 | -1.2% | |
| Feb 19, 2016 | PAHC Phibro Animal Health Corp | Carlson Gerald K | Chief Operating Officer | Sell | 8,000 | $28.09 | $224,720.00 | -100% | |
| Feb 17, 2016 | JNJ Johnson & Johnson | Stoffels Paulus | Chief Scientific Officer | Sell | 125,000 | $102.43 | $12,803,250.00 | -50.5% | |
| Feb 17, 2016 | NVS Novartis AG | Novartis Bioventures Ltd | 10% Owner | Buy | 375,000 | $8.00 | $3,000,000.00 | +25.0% | |
| Feb 17, 2016 | PAHC Phibro Animal Health Corp | Bfi Co., LLC | 10% Owner | Sell | 2,175 | $30.01 | $65,271.75 | -2.9% | |
| Feb 17, 2016 | PCRX Pacira Biosciences, Inc. | Hastings Paul J75 | Director | Sell | 3,000 | $60.00 | $180,000.00 | -51.3% | |
| Feb 17, 2016 | PAHC Phibro Animal Health Corp | Bendheim Jack52 | President And CEO | Sell | 2,175 | $30.01 | $65,271.75 | -2.9% | |
| Feb 17, 2016 | SNY Sanofi | Sanofi | 10% Owner | Buy | 161,157 | $392.46 | $63,247,909.95 | - | |
| Feb 17, 2016 | PRGO Perrigo Co Plc | Perrigo Co Plc | 10% Owner | Buy | 125,000 | $8.00 | $1,000,000.00 | +4.5% | |
| Feb 17, 2016 | ELTP Elite Pharmaceuticals Inc /nv/ | Treppel Jerry | Former Chairman | Sell | 909,878 | $0.33 | $301,266.14 | -1.5% | |
| Feb 11, 2016 | CANN Trees Corp (colorado) | Frichtel Robert Lawrence | CEO | Buy | 4,000 | $0.39 | $1,560.00 | +0.4% | |
| Feb 11, 2016 | CANN Trees Corp (colorado) | Feinsod Michael | Director | Buy | 3,000 | $0.41 | $1,222.50 | +23.6% | |
| Feb 10, 2016 | PAHC Phibro Animal Health Corp | Bfi Co., LLC | 10% Owner | Sell | 3,400 | $30.78 | $104,652.00 | -4.4% | |
| Feb 10, 2016 | PAHC Phibro Animal Health Corp | Bendheim Jack52 | President And CEO | Sell | 3,400 | $30.78 | $104,652.00 | -4.4% | |
| Feb 5, 2016 | BCRX Biocryst Pharmaceuticals Inc | Baker Bros. Advisors LP59 | 10% Owner | Buy | 45,000 | $6.33 | $284,656.50 | +0.4% | |
| Feb 5, 2016 | LLY Eli Lilly & Co | Fry Stephen F | SVP, Hr &Diversity | Sell | 15,230 | $78.87 | $1,201,190.10 | -20.3% | |
| Feb 4, 2016 | LFCR Lifecore Biomedical, Inc. \de\ | Frank Fred | Director | Sell | 4,573 | $12.00 | $54,876.00 | -11.3% | |
| Feb 4, 2016 | BCRX Biocryst Pharmaceuticals Inc | Baker Bros. Advisors LP59 | 10% Owner | Buy | 207,715 | $6.43 | $1,336,586.04 | +0.5% | |
| Feb 3, 2016 | JNJ Johnson & Johnson | Fasolo Peter61 | VP, Global Human Resources | Sell | 151,385 | $104.12 | $15,762,008.51 | -66.7% | |
| Feb 3, 2016 | PAHC Phibro Animal Health Corp | Bendheim Jack52 | President And CEO | Sell | 12,000 | $33.39 | $400,640.00 | -5.4% | |
| Feb 3, 2016 | LLY Eli Lilly & Co | Rice Derica W | Evp-global Services And CFO | Sell | 10,483 | $77.78 | $815,345.53 | -11.9% | |
| Feb 3, 2016 | PAHC Phibro Animal Health Corp | Bfi Co., LLC | 10% Owner | Sell | 12,000 | $33.39 | $400,640.00 | -5.4% | |
| Feb 3, 2016 | LLY Eli Lilly & Co | Fry Stephen F | SVP, Hr &Diversity | Sell | 3,137 | $77.94 | $244,510.18 | -2.0% | |
| Feb 3, 2016 | LLY Eli Lilly & Co | Ricks David A51 | SVP And Pres, Lilly Bio-meds | Sell | 5,733 | $77.66 | $445,228.08 | -3.4% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.